Tue.Jan 10, 2023

article thumbnail

Examining the Risk of COVID-19 in the Vaccinated

Drug Topics

Researchers at Cleveland Clinic evaluated whether a bivalent COVID-19 vaccine protects against both strains of the virus - the original virus strain and a component of the omicron variant.

Vaccines 469
article thumbnail

C-suite changes at Biogen, Bluebird, Klick Health give insight into 2023 business plans

PharmaVoice

A breakdown of the most buzzworthy executive changes so far in the new year and how they’re causing ripples in the life sciences industry.

147
147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medication Dosing in Pediatric Obesity Presents Complexities and Challenges

Drug Topics

Careful thought and adjustments are required to avoid exceeding the maximum recommended amount.

469
469
article thumbnail

Wearable Device Accurately Tracks Heart Failure Progression

Pharmacy Times

Approximately half of patients with heart failure do not require an implantable monitoring device or do not qualify for thoracic monitoring.

139
139
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

For Pharmacists, Building Resilience and Well-Being Is Critical

Drug Topics

Pharmacists can use a variety of tools to foster resilience and prevent burnout.

469
469
article thumbnail

Mistakes happen in research papers. But corrections often don’t

STAT

Mistakes happen — in life, in the lab, and, inevitably, in research papers, too. Journals use corrections and retractions to resolve those mistakes. But one particularly high-profile case is now drawing fresh attention to the problems with journals’ process for addressing concerns about research integrity. Late last year, Stanford University announced that it was opening an investigation into its president, neuroscientist Marc Tessier-Lavigne, over allegations of research misconduc

137
137

More Trending

article thumbnail

Use of Telehealth Services for Mental Health Dramatically Increased in 2020, Offsetting Rapid Decline of In-Person Care

Pharmacy Times

Individuals in metropolitan counties used mental health services more than individuals in rural counties.

132
132
article thumbnail

Two Eye Diseases Could Contribute to Common Blinding Eye Condition

Drug Topics

The study could lead to early diagnosis and treatment of age-related macular degeneration.

464
464
article thumbnail

Report Identifies 15 Key Drugs Predicted to Achieve Blockbuster Status by 2027

Pharmacy Times

The report highlights the growth of personalized medicines with improved efficacy for rare, previously untreatable diseases.

132
132
article thumbnail

JPM23: CVS Health still weighing next steps as it plans foray into primary care

Fierce Healthcare

JPM23: CVS Health still weighing next steps as it plans foray into primary care. pminemyer. Tue, 01/10/2023 - 12:37.

130
130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Depression Associated With Lower Medication Adherence Post-Percutaneous Coronary Intervention

Pharmacy Times

Patients with depression were significantly less likely to have adequate 12-month adherence to antiplatelets, β-blockers, and statins than those without depression.

131
131
article thumbnail

Chinook Therapeutics nears the finish line in kidney disease

PharmaVoice

A company focused on kidney disease, Chinook is growing into a commercial outfit as its lead candidate approaches the market.

130
130
article thumbnail

LeanTaaS, Hospital IQ join forces to address hospital operational optimization

Fierce Healthcare

LeanTaaS, Hospital IQ join forces to address hospital operational optimization. aburky. Tue, 01/10/2023 - 15:00.

Hospitals 128
article thumbnail

JPM23: Pfizer entering the 'most important' 18-month stretch in company history, CEO says

Fierce Pharma

JPM23: Pfizer entering the 'most important' 18-month stretch in company history, CEO says. esagonowsky. Tue, 01/10/2023 - 08:51.

123
123
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Former CDC Director Discusses Public Health's Impact on National Policy

Pharmacy Times

The first episode of the Public Health Matters Video Series features Tom Frieden, MPH, MD, who discusses his background and influence on public health and national policy.

122
122
article thumbnail

Medicare Advantage, telehealth expansion allies to helm key House panels

Fierce Healthcare

Medicare Advantage, telehealth expansion allies to helm key House panels. rking. Tue, 01/10/2023 - 17:25.

119
119
article thumbnail

JPM23: Novavax hopes end of COVID emergency—and open vaccine market—will help it grow market share

Fierce Pharma

JPM23: Novavax hopes end of COVID emergency—and open vaccine market—will help it grow market share. aarmstrong. Tue, 01/10/2023 - 10:24.

Vaccines 116
article thumbnail

With attention to mpox fading, health officials fear infections will go undetected and unreported

STAT

In the transmission heyday of the international mpox outbreak early last summer, it appeared that containment might not be possible. In recent months, though, the rate of growth of new cases has slowed considerably in a number of countries. In the United States, daily case reports have been in the single digits since mid-December; the U.K. hasn’t reported a new case since before Christmas.

115
115
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

CVS reportedly in discussions to acquire Oak Street Health

Drug Store News

If reached, the deal would value Oak Street at more than $10 billion, including debt, according to a Bloomberg report.

111
111
article thumbnail

JPM23: Ascension Health details $2.5B economic recovery plan to rebound from financial, operational headwinds

Fierce Healthcare

JPM23: Ascension Health details $2.5B economic recovery plan to rebound from financial, operational headwinds. hlandi. Wed, 01/11/2023 - 00:06.

110
110
article thumbnail

STAT+: Insurers hint at suing Biden administration over plans for Medicare Advantage audits

STAT

Big health insurers who spoke at the J.P. Morgan Healthcare Conference are gearing up to battle the Biden administration once it finalizes its plan for auditing Medicare Advantage, which is expected to happen next month. Executives from Humana, Centene, and CVS Health-Aetna aired concerns about the forthcoming final rule on the audits, known as risk adjustment data validation, or RADV.

Insurance 109
article thumbnail

Employer-sponsored coverage flatlined even as unemployment rate shrunk: study

Fierce Healthcare

Employer-sponsored coverage flatlined even as unemployment rate shrunk: study. fdiamond. Tue, 01/10/2023 - 14:31.

109
109
article thumbnail

Vitamin D Supplementation Linked to Fewer Cases of Melanoma

Pharmacy Times

In the geographical region of a recent study, data showed melanoma cause high mortality rates in relation to incidence.

107
107
article thumbnail

JP Morgan 2023 – Day 2

pharmaphorum

Tuesday brings the on-site part of Fierce’s JPM event as well as day 2 of the Informa Biotech Showcase. We’ll do our best to surf between the two, as well as providing remote updates where we can from the main event. Fierce’s event “The long haul: How pharma and healthcare can survive in 2023” will feature guests from Bayer, Takeda, Genentech, and more.

106
106
article thumbnail

PharmaSmart finds consumers value clinical validation at blood pressure kiosks

Drug Store News

A study conducted by PharmaSmart found that 81% of users will share their validated PharmaSmart blood pressure readings with their pharmacist and 92% will share readings with their physician.

106
106
article thumbnail

BMA: Medicare Advantage outperforms fee-for-service on certain diabetes outcomes

Fierce Healthcare

BMA: Medicare Advantage outperforms fee-for-service on certain diabetes outcomes. rking. Tue, 01/10/2023 - 13:17.

105
105
article thumbnail

A Holiday Surprise; FTC Published Its Health Products Compliance Guidance

The FDA Law Blog

By Riëtte van Laack & Ricardo Carvajal — On Dec. 20, 2022, FTC announced the publication of its Health Products Compliance Guidance (“new Guidance”). FTC staff prepared the new Guidance to update and replace Dietary Supplements: An Advertising Guide for Industry , issued in 1998 (“1998 Guidance”). The new Guidance provides the first update in 25 years on FTC’s thinking regarding substantiation and disclosures for health-related claims.

article thumbnail

RxBar shakes up breakfast with granola, Craft Batch innovations

Drug Store News

RxBar is launching a line of granola that comes in three varities, as well as its first Craft Batch flavor.

105
105
article thumbnail

Lack of medicines in Greece and the solution of Generics

Pharma Tutor

Lack of medicines in Greece and the solution of Generics. admin. Tue, 01/10/2023 - 15:46. Georgios-Marios Bolmpasis. MPharm Student University of Athens. Vice President of Pharmacy Students Association(Athens).

105
105
article thumbnail

JPM23, Day 2: Cigna focusing on partnerships in primary care strategy; Omada, Intermountain launch partnership for diabetes care

Fierce Healthcare

JPM23, Day 2: Cigna focusing on partnerships in primary care strategy; Omada, Intermountain launch partnership for diabetes care. hlandi. Tue, 01/10/2023 - 11:15.

105
105
article thumbnail

JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals

Fierce Pharma

JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals. kdunleavy. Tue, 01/10/2023 - 06:24.

Vaccines 105
article thumbnail

Opinion: Is the golden age of biotech stocks over?

STAT

Much of the last decade felt like the golden age of biotechnology investing. Money — lots of money — was poured into new gene therapies that replaced defective genes with healthy ones, immunotherapies that were game changers for people with cancer, innovative medicines for rare diseases and HIV, and more. The returns on biotech stocks were phenomenal.

102
102
article thumbnail

Concern as proportion of children in England on antipsychotics doubles

The Guardian - Pharmaceutical Industry

Researchers find overall percentage increase from 0.06% in 2000 to 0.11% in 2019 although safety in children not fully established The proportion of children and young people prescribed antipsychotics in England has nearly doubled in just two decades, prompting concern among some experts. The powerful drugs are often used to treat major mental illnesses, such as schizophrenia, in adults.

99